Perfusion imaging quantifies the characteristics of blood flow in tissues: Dynamic susceptibility contrast MRI quantifies relative cerebral blood volume. These quantitative maps offer information to predict tumor grade and analyze post treatment changes for glioblastoma multiforme, meningioma, astrocytoma and oligodendroglioma.
- Çoban, G., et al. “Prognostic value of dynamic susceptibility contrast-enhanced and diffusion-weighted MR imaging in patients with glioblastomas.” American Journal of Neuroradiology (2015).
- Lee, B., et al. “Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.” American Journal of Neuroradiology (2018).
- IB Neuro – FDA cleared, CE marked
- DSC-MRI analysis tool (Imaging Biometrics)
FDA cleared: FDA cleared
Company: Imaging Biometrics